Engineering the maturation of stem cell-derived cardiomyocytes

Front Bioeng Biotechnol. 2023 Mar 22:11:1155052. doi: 10.3389/fbioe.2023.1155052. eCollection 2023.

Abstract

The maturation of human stem cell-derived cardiomyocytes (hSC-CMs) has been a major challenge to further expand the scope of their application. Over the past years, several strategies have been proven to facilitate the structural and functional maturation of hSC-CMs, which include but are not limited to engineering the geometry or stiffness of substrates, providing favorable extracellular matrices, applying mechanical stretch, fluidic or electrical stimulation, co-culturing with niche cells, regulating biochemical cues such as hormones and transcription factors, engineering and redirecting metabolic patterns, developing 3D cardiac constructs such as cardiac organoid or engineered heart tissue, or culturing under in vivo implantation. In this review, we summarize these maturation strategies, especially the recent advancements, and discussed their advantages as well as the pressing problems that need to be addressed in future studies.

Keywords: 3D cardiac organoid; biochemical cues; cardiomyocytes; in vivo implantation; maturation; metabolic engineering; physical cues; stem cell.

Publication types

  • Systematic Review

Grants and funding

This work was funded by the National Key R&D Program of China (2022YFA1104800), National Natural Science Foundation of China (82170506), Beijing Nova Program (20220484100), the open research fund of State Key Laboratory of Cardiovascular Disease, Fuwai Hospital (2022KF-04), Clinical Medicine Plus X—Young Scholars Project, Peking University (PKU2022LCXQ003).